Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Scientific Reports|June 15, 2021
Embedding supervised exercise training for men on androgen deprivation therapy into standard prostate cancer care: a feasibility and acceptability study (the STAMINA trial)Sophie Reale, Rebecca R Turner, Eileen Sutton, et al.
JAMA|July 11, 2013
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trialMaarten C Bosland, Ikuko Kato, Anne Zeleniuch-Jacquotte, et al.
European Radiology|January 6, 2026
Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation resultsSungmin Woo, Angela Tong, Anton S Becker, et al.
The Prostate|March 29, 2023
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profileVictor R Adorno Febles, Yuan Hao, Aarif Ahsan, et al.
The Journal of Urology|June 10, 2026
Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and ToxicityArvin George, Eric Giesler, Brian Mazzarella, et al.
Lancet (London, England)|November 8, 2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialPadraig Warde, Malcolm Mason, Keyue Ding, et al.
European Urology|April 7, 2026
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 TrialMinas P Economides, Peter H O'Donnell, Ajjai S Alva, et al.
European Urology|March 30, 2013
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working GroupCaroline M Moore, Veeru Kasivisvanathan, Scott Eggener, et al.
The Lancet. Oncology|March 13, 2022
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trialDavid Dearnaley, Victoria Hinder, Adham Hijab, et al.
The Lancet. Oncology|February 5, 2019
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based studyAmy Downing, Penny Wright, Luke Hounsome, et al.
Pageof 29